CDMO Education Centre

Understanding Reprogramming of Induced Pluripotent Stem Cells, and Considerations for Use in GMP Manufacturing

close

Categories

See More

Subscribe to Email Updates

Popular Stories

Developing an Analytical Development Strategy for Immunotherapy Feb 13, 2024
The Canadian Regulatory System for Cell and Gene Therapies Apr 13, 2022
Finding Your Goldilocks: Choosing the Ideal Cell and Gene Therapy CDMO Mar 08, 2024
Understanding Reprogramming of Induced Pluripotent Stem Cells, and Considerations for Use in GMP Manufacturing May 27, 2024
The Vital Role of Process Closure and Automation in CAR T Manufacturing Apr 09, 2024
Categories | Subscribe | Popular
27 May 2024

Understanding Reprogramming of Induced Pluripotent Stem Cells, and Considerations for Use in GMP Manufacturing

It was less than 20 years ago that the foundational study by Takahashi...

08 Dec 2022

The 3 Best Ways to Manufacture and Scale Up Lentiviral Vectors

LVVs are essential in the manufacture of cellular immunotherapies (e.g...

08 Dec 2022

Upstream and Downstream Considerations for Scaling Up Lentiviral Vector Production

Lentiviral vectors (LVVs) are often used to deliver genetic material f...

18 Aug 2022

Top 6 Tips to Speed Up Manufacturing Your CGT Product

Managing the manufacturing process for cell and gene therapy (CGT) pro...

Tell us what you thought about this post.

You may also like:

Business people meeting around table in modern space

Subscribe to our blog.

Receive updates on the latest trends in cell & gene therapy.

Subscribe to Email Updates

© 2024 All Rights Reserved